Literature DB >> 23288467

Prognostic value of NT-pro-BNP and hs-CRP for risk stratification in primary care: results from the population-based DETECT study.

David M Leistner1, Jens Klotsche, Lars Pieper, Sylvia Palm, Günter K Stalla, Hendrik Lehnert, Sigmund Silber, Winfried März, Hans-Ulrich Wittchen, Andreas M Zeiher.   

Abstract

BACKGROUND: There is continuous debate to the use of biomarkers in the general practitioners office and to what degree the established biomarkers N-terminal pro-B-type natriuretic peptide (NT-pro-BNP) and high-sensitive C-reactive protein (hs-CRP) might contribute to improved prediction of incident cardiovascular events.
OBJECTIVE: To evaluate the utility and 5-year predictive value of a single measurement of NT-pro-BNP and hs-CRP for incident cardiovascular events, and its added value beyond the contribution of conventional risk factors in primary care.
METHODS: Five year prospective longitudinal clinical epidemiological study in a nationwide sample of 4,775 primary care subjects (mean age 55.8 years, 62 % women) without coronary artery disease at baseline. Main outcome measures were incident major cardiovascular events and all-cause death.
RESULTS: During the 5 years of follow-up, 188 subjects (3.9 %) died or experienced a first major cardiovascular event. The addition of NT-pro-BNP, but not of hs-CRP to a prediction model with established cardiovascular risk factors improved the prediction of major cardiovascular events (increase in C statistic by 0.009; p = 0.008), and was associated with a significant improvement in net reclassification improvement (NRI = 23.6 %; p = 0.003).
CONCLUSION: In a primary care setting, one single measurement of NT-pro-BNP, but not of hs-CRP significantly improves the prediction of incident cardiovascular events.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23288467     DOI: 10.1007/s00392-012-0530-5

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN: 1861-0684            Impact factor:   5.460


  34 in total

1.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

Authors: 
Journal:  Circulation       Date:  2002-12-17       Impact factor: 29.690

Review 2.  AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association Science Advisory and Coordinating Committee.

Authors:  Thomas A Pearson; Steven N Blair; Stephen R Daniels; Robert H Eckel; Joan M Fair; Stephen P Fortmann; Barry A Franklin; Larry B Goldstein; Philip Greenland; Scott M Grundy; Yuling Hong; Nancy Houston Miller; Ronald M Lauer; Ira S Ockene; Ralph L Sacco; James F Sallis; Sidney C Smith; Neil J Stone; Kathryn A Taubert
Journal:  Circulation       Date:  2002-07-16       Impact factor: 29.690

3.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors:  S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal:  N Engl J Med       Date:  2000-01-20       Impact factor: 91.245

4.  The changing face of cardiovascular risk.

Authors:  Scott M Grundy
Journal:  J Am Coll Cardiol       Date:  2005-07-05       Impact factor: 24.094

5.  Comparative impact of multiple biomarkers and N-Terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study.

Authors:  Stefan Blankenberg; Matthew J McQueen; Marek Smieja; Janice Pogue; Cynthia Balion; Eva Lonn; Hans J Rupprecht; Christoph Bickel; Laurence Tiret; Francois Cambien; Hertzel Gerstein; Thomas Münzel; Salim Yusuf
Journal:  Circulation       Date:  2006-07-10       Impact factor: 29.690

6.  Evaluating the yield of medical tests.

Authors:  F E Harrell; R M Califf; D B Pryor; K L Lee; R A Rosati
Journal:  JAMA       Date:  1982-05-14       Impact factor: 56.272

7.  C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction.

Authors:  P M Ridker; R J Glynn; C H Hennekens
Journal:  Circulation       Date:  1998-05-26       Impact factor: 29.690

8.  Prevalence of conventional risk factors in patients with coronary heart disease.

Authors:  Umesh N Khot; Monica B Khot; Christopher T Bajzer; Shelly K Sapp; E Magnus Ohman; Sorin J Brener; Stephen G Ellis; A Michael Lincoff; Eric J Topol
Journal:  JAMA       Date:  2003-08-20       Impact factor: 56.272

9.  Contribution of 30 biomarkers to 10-year cardiovascular risk estimation in 2 population cohorts: the MONICA, risk, genetics, archiving, and monograph (MORGAM) biomarker project.

Authors:  Stefan Blankenberg; Tanja Zeller; Olli Saarela; Aki S Havulinna; Frank Kee; Hugh Tunstall-Pedoe; Kari Kuulasmaa; John Yarnell; Renate B Schnabel; Philipp S Wild; Thomas F Münzel; Karl J Lackner; Laurence Tiret; Alun Evans; Veikko Salomaa
Journal:  Circulation       Date:  2010-05-24       Impact factor: 29.690

10.  Release pattern of N-terminal pro B-type natriuretic peptide (NT-proBNP) in acute coronary syndromes.

Authors:  M Weber; C Kleine; E Keil; M Rau; A Berkowitsch; A Elsaesser; V Mitrovic; C Hamm
Journal:  Clin Res Cardiol       Date:  2006-03-21       Impact factor: 6.138

View more
  18 in total

1.  Higher plasma levels of MR-pro-atrial natriuretic peptide are linked to less anxiety: results from the observational DIAST-CHF study.

Authors:  Thomas Meyer; Christoph Herrrmann-Lingen; Mira-Lynn Chavanon; Kathleen Nolte; Caroline Anna Pasedach; Lutz Binder; Burkert Pieske; Gerd Hasenfuss; Rolf Wachter; Frank Edelmann
Journal:  Clin Res Cardiol       Date:  2015-02-10       Impact factor: 5.460

2.  B-type natriuretic peptide: distribution in the general population and the association with major cardiovascular and coronary events--the Heinz Nixdorf Recall Study.

Authors:  Kaffer Kara; Amir A Mahabadi; Marie H Geisel; Nils Lehmann; Hagen Kälsch; Marcus Bauer; Till Neumann; Nico Dragano; Susanne Moebus; Stefan Möhlenkamp; Karl-Heinz Jöckel; Raimund Erbel
Journal:  Clin Res Cardiol       Date:  2013-10-15       Impact factor: 5.460

3.  Heart rate turbulence and deceleration capacity for risk prediction of serious arrhythmic events in Marfan syndrome.

Authors:  Benjamin N Schaeffer; Meike Rybczynski; Sara Sheikhzadeh; Ruken Ö Akbulak; Julia Moser; Mario Jularic; Doreen Schreiber; Anne Daubmann; Stephan Willems; Yskert von Kodolitsch; Boris A Hoffmann
Journal:  Clin Res Cardiol       Date:  2015-06-02       Impact factor: 5.460

Review 4.  Physiology of natriuretic peptides: The volume overload hypothesis revisited.

Authors:  Olli Arjamaa
Journal:  World J Cardiol       Date:  2014-01-26

5.  Improvement of risk assessment in systemic light-chain amyloidosis using human placental growth factor.

Authors:  Arnt V Kristen; Johannes Rinn; Ute Hegenbart; David Lindenmaier; Corina Merkle; Christoph Röcken; Stefan Hardt; Evangelos Giannitsis; Hugo A Katus
Journal:  Clin Res Cardiol       Date:  2014-10-21       Impact factor: 5.460

6.  Association of multiple biomarkers and classical risk factors with early carotid atherosclerosis: results from the Gutenberg Health Study.

Authors:  Christoph Sinning; Arne Kieback; Philipp S Wild; Renate B Schnabel; Francisco Ojeda; Sebastian Appelbaum; Tanja Zeller; Edith Lubos; Edzard Schwedhelm; Karl J Lackner; Eike S Debus; Thomas Munzel; Stefan Blankenberg; Christine Espinola-Klein
Journal:  Clin Res Cardiol       Date:  2014-02-02       Impact factor: 5.460

7.  Approach to risk stratification of atherosclerotic cardiovascular disease: Use of biomarkers and imaging in a Canadian context.

Authors:  Daniel Esau; Beth L Abramson
Journal:  Can Fam Physician       Date:  2022-09       Impact factor: 3.025

Review 8.  Clinical significance of Helicobacter pylori infection in patients with acute coronary syndromes: an overview of current evidence.

Authors:  Jacek Budzyński; Marek Koziński; Maria Kłopocka; Julia Maria Kubica; Jacek Kubica
Journal:  Clin Res Cardiol       Date:  2014-05-10       Impact factor: 5.460

9.  Predictive value of the novel risk score BETTER (BiomarkErs and compuTed Tomography scorE on Risk stratification) for patients with unstable angina.

Authors:  Y Xia; Y Xia; K Xu; Y Ma; D Pan; T Xu; L Lu; D Li
Journal:  Herz       Date:  2014-08-31       Impact factor: 1.443

10.  Prognostic role of N-terminal pro-brain natriuretic peptide in asymptomatic hypertensive and diabetic patients in primary care: impact of age and gender : Results from the PROBE-HF study.

Authors:  Piercarlo Ballo; Irene Betti; Alessandro Barchielli; Daniela Balzi; Gabriele Castelli; Leonardo De Luca; Mihai Gheorghiade; Alfredo Zuppiroli
Journal:  Clin Res Cardiol       Date:  2015-11-07       Impact factor: 5.460

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.